Related Experiment Video
Updated: Feb 6, 2026

Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue
Published on: October 26, 2014
Metformin Plus Caloric Restriction Show Anti-epileptic Effects Mediated by mTOR Pathway Inhibition
María Del Carmen Rubio Osornio1, Verónica Custodio Ramírez1, Daniela Calderón Gámez2
1Laboratorio de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía, Av. Insurgentes Sur 3877, Col. La Fama, Del. Tlalpan, 14269, Mexico City, Mexico.
Abstract:
Caloric restriction (CR) has anti-epileptic effects in different animal models, at least partially due to inhibition of the mechanistic or mammalian target of rapamycin (mTOR) signaling pathway. Adenosine monophosphate-activated protein kinase (AMPK) inhibits mTOR cascade function if energy levels are low. Since hyper-activation of mTOR participates in epilepsy, its inhibition results in beneficial anti-convulsive effects. A way to attain this is to activate AMPK with metformin. The effects of metformin, alone or combined with CR, on the electrical kindling epilepsy model and the mTOR cascade in the hippocampus and the neocortex were studied. Combined metformin plus CR beneficially affected many kindling aspects, especially those relating to generalized convulsive seizures. Therefore, metformin plus CR could decrease measures of epileptic activity in patients with generalized convulsive seizures. Patients that are obese, overweight or that have metabolic syndrome in addition to having an epileptic disease are an ideal population for clinical trials to test the effectiveness of metformin plus CR.
Insights
Caloric restriction combined with metformin shows anti-epileptic effects by inhibiting the mTOR pathway. This combination therapy is promising for patients with generalized convulsive seizures, particularly those who are overweight or have metabolic syndrome.
Area of Science:
- Neuroscience
- Metabolic Disorders
Background:
- Caloric restriction (CR) demonstrates anti-epileptic properties, partly by inhibiting the mechanistic/mammalian target of rapamycin (mTOR) pathway.
- Adenosine monophosphate-activated protein kinase (AMPK) activation, triggered by low energy levels, inhibits mTOR signaling.
Purpose of the Study:
- To investigate the effects of metformin, alone and in combination with CR, on an electrical kindling epilepsy model.
- To examine the impact on the mTOR cascade in the hippocampus and neocortex.
Main Methods:
- Utilized an electrical kindling epilepsy model in animals.
- Administered metformin and caloric restriction, both individually and in combination.
- Analyzed mTOR signaling pathway activity in hippocampal and neocortical tissues.
Main Results:
- The combination of metformin and CR significantly improved various aspects of kindling, particularly reducing generalized convulsive seizures.
- Metformin and CR demonstrated a combined beneficial effect on seizure measures.
Conclusions:
- Metformin combined with caloric restriction may reduce epileptic activity in patients experiencing generalized convulsive seizures.
- Obese or overweight patients with epilepsy and metabolic syndrome are ideal candidates for clinical trials evaluating this combined therapy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Feedback Inhibition
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

